Kiyokawa Etsuko, Minato Hiroshi
Department of Oncologic Pathology and Department of Pathology and Laboratory Medicine, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa 920-0293, Japan
Department of Oncologic Pathology and Department of Pathology and Laboratory Medicine, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa 920-0293, Japan.
J Biochem. 2014 Sep;156(3):137-45. doi: 10.1093/jb/mvu041. Epub 2014 Jun 23.
RAS genes are frequently mutated in various human tumours. These mutations cause GTPase RAS to remain locked in constitutively active signals through the downstream cascades leading to proliferation. A series of earlier studies reported on the morphological appearance of cells upon RAS activation. Classically, morphologic changes of fibroblasts have been used to confirm the oncogenic activity of RAS. Recent works found that the active RAS induces benign and malignant morphological changes in organoids, which are an in vitro model system for epithelial tissue. The studies of animal models support the basic oncogenic features of RAS revealed in vitro, while also providing evidence that the effects of RAS activation in vivo are different from those in vitro. The pathological observation of the various human materials indicates that the oncogenic RAS participates in metaplasia, which occurs before proliferation, and that RAS promotes mucin production in various organs. These morphological analyses may shed light on important signalling pathways that merit investigation in vitro.
RAS基因在各种人类肿瘤中经常发生突变。这些突变导致GTPase RAS通过导致增殖的下游级联反应保持锁定在组成型活性信号中。一系列早期研究报道了RAS激活后细胞的形态外观。传统上,成纤维细胞的形态变化已被用于确认RAS的致癌活性。最近的研究发现,活性RAS在类器官中诱导良性和恶性形态变化,类器官是上皮组织的体外模型系统。动物模型研究支持了体外揭示的RAS的基本致癌特征,同时也提供了证据表明RAS在体内的激活作用与体外不同。对各种人类材料的病理观察表明,致癌性RAS参与化生,化生发生在增殖之前,并且RAS促进各种器官中粘蛋白的产生。这些形态学分析可能会揭示一些值得在体外研究的重要信号通路。